The downgrade is a result of several factors, including Parkland’s weak net leverage profile, unfavorable payer mix and limited cost flexibility. Fitch also acknowledged Parkland’s $1 billion tax margin to support operations, strong service area with population growth and moderate capital needs.
The outlook is stable at the lower rating.
More articles on healthcare finance:
Physicians: Is CHS ‘a slow-motion train wreck?’
California hospital to close by mid-June, lay off 200 employees
Tenet posts surprise $99M profit after expanding cost-cutting plan
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
